Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoblastic Lymphadenopathy × Ipilimumab × 90 days × Clear all

Sponsor

Conditions

Melanoma 27 Carcinoma, Renal Cell 16 Carcinoma, Non-Small-Cell Lung 15 Neoplasm Metastasis 9 Skin Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 5 Lung Neoplasms 5 Kidney Neoplasms 5 Carcinoma, Hepatocellular 5 Brain Neoplasms 5 Urinary Bladder Neoplasms 4 Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Merkel Cell 4 Urogenital Neoplasms 3 Urethral Neoplasms 3 Small Cell Lung Carcinoma 3 Prostatic Neoplasms 3 Penile Neoplasms 3 Pancreatic Neoplasms 3 Mesothelioma, Malignant 3 Glioblastoma 3 Uveal Melanoma 2 Ureteral Neoplasms 2 Sarcoma 2 Recurrence 2 Rectal Neoplasms 2 Neuroendocrine Tumors 2 Myelodysplastic Syndromes 2

Interventions

Cyclophosphamide 2 tazemetostat 1 romidepsin 1 pembrolizumab 1 glofitamab 1 fludarabine 1 etoposide phosphate 1 duvelisib 1 brincidofovir 1 belinostat 1 Vincristine 1 Valganciclovir 1 Therapeutics 1 Prednisone 1 Prednisolone 1 Polymerase Chain Reaction 1 Melphalan 1 Lactones 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Etoposide 1 Doxorubicin 1 Depsipeptides 1 Cytarabine 1 Cholecalciferol 1 Carmustine 1 Bendamustine Hydrochloride 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡